Pharmacogenetics and heart failure: a convergence with carvedilol.
Meadowcroft
A M
AM
Williamson
K M
KM
Patterson
J H
JH
Pieper
J A
JA
D000319:Adrenergic beta-Antagonists / Q000378:metabolism* / Q000627:therapeutic use; D002227:Carbazoles / Q000378:metabolism* / Q000627:therapeutic use; D000077261:Carvedilol; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics / Q000378:metabolism*; D006333:Heart Failure / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D010597:Pharmacogenetics; D011412:Propanolamines / Q000378:metabolism* / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000378:metabolism* / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D011412:Propanolamines; D014665:Vasodilator Agents; D000077261:Carvedilol; D019389:Cytochrome P-450 CYP2D6